1. Home
  2. Companies
  3. LTP
  4. Announcements

Ltr Pharma (ASX:LTP)

ASX announcement history & article coverage

15
Total announcements
(in last 3 months)
10
With article
5
No article
Article coverage
67%
Transparent by design. Announcments by Ltr Pharma (ASX:LTP) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.

4 Sept 2026 · 03:58 pm AEST ASX Filing
Application for quotation of securities - LTP
Appendix 2A
3 Sept 2026 · 08:32 am AEST ASX Filing
Investor Presentation
Company Presentation
1 Sept 2026 · 08:15 am AEST ASX Filing
LTR Expands Men's Health Portfolio with KYZATREX Pilot
Progress Report

28 Aug 2026 · 07:48 am AEST ⚡ Price SensitiveMaterial ASX Filing
FY26 Results Announcement
LTR Pharma advances clinical programs and secures US commercial pathway with strong FY26 results
Preliminary Final Report
85
LTR Pharma Advances US Market Entry with ROXUS Deals and SPONTAN Phase II Progress
28 Aug 2026 · 07:48 am AEST ASX Filing
Appendix 4G and Corporate Governance Statement
Corporate GovernanceAppendix 4G
28 Aug 2026 · 07:48 am AEST ⚡ Price SensitiveMaterial ASX Filing
Appendix 4E and Annual Report to Shareholders
LTR Pharma advances intranasal ED therapies with US commercial deals and clinical progress, reports FY26 loss of A$14.16 million
Annual ReportTop 20 shareholders
85
LTR Pharma Advances US Market Entry with ROXUS Deals and SPONTAN Phase II Progress Healthcare Wrap - Week 35 (24 Aug -> 28 Aug) 2026 Wrap
11 Aug 2026 · 08:32 am AEST ⚡ Price SensitiveMaterial ASX Filing
SPONTAN Real-World Study Reports 93% Response
LTR Pharma's SPONTAN shows 93% response in convenience-seeking men and 64% in post-prostatectomy patients
Progress Report
85
LTR Pharma’s SPONTAN Shows Strong Real-World Response in Post-Prostatectomy and Convenience-Seeking Men Healthcare Wrap - Week 33 (10 Aug -> 14 Aug) 2026 Wrap

28 July 2026 · 09:01 am AEST ⚡ Price SensitiveMaterial ASX Filing
Quarterly Activities/Appendix 4C Cash Flow Report
LTR Pharma advances clinical and commercial milestones with SPONTAN Phase II data and US ROXUS launch agreements
Commitments Test Entity - Fourth Quarter Activity ReportCommitments Test Entity - Fourth Quarter Cashflow Report
85
LTR Pharma Advances US Launch with SPONTAN Phase II Data and ROXUS Agreements Healthcare Wrap - Week 31 (27 July -> 31 July) 2026 Wrap
20 July 2026 · 08:55 am AEST ⚡ Price SensitiveMaterial ASX Filing
LTR Executes U.S. Commercial Agreement with Strive
LTR Pharma finalizes U.S. commercial agreement with Strive Pharmacy for ROXUS® launch
Progress Report
80
LTR Pharma Secures Definitive US Manufacturing Deal for ROXUS Launch Healthcare Wrap - Week 30 (20 July -> 24 July) 2026 Wrap
17 July 2026 · 08:48 am AEST ⚡ Price SensitiveMaterial ASX Filing
LTR Executes Definitive U.S. Commercial Agreement with Shed
LTR Pharma signs definitive U.S. commercial agreement with Shed for ROXUS® launch
Progress Report
85
LTR Pharma Secures Definitive US Deal with Shed to Launch ROXUS Intranasal ED Treatment Healthcare Wrap - Week 29 (13 July -> 17 July) 2026 Wrap Market Wrap - Week 29 (13 July -> 17 July) 2026 Wrap
10 July 2026 · 04:28 pm AEST ASX Filing
Notification regarding unquoted securities - LTP
Appendix 3G

24 June 2026 · 08:22 am AEST Material ASX Filing
OROFLOW Clinical Study Receives Ethics Approval
LTR Pharma's OROFLOW® Intranasal Spray Approved for Clinical Study in Oesophageal Motility Disorders
Progress Report
75
LTR Pharma’s OROFLOW® Gains Ethics Nod to Target $8 Billion Oesophageal Motility Market Healthcare Wrap - Week 26 (22 June -> 26 June) 2026 Wrap
15 June 2026 · 02:16 pm AEST ⚡ Price SensitiveMaterial ASX Filing
Response to ASX Aware Letter
LTR Pharma confirms timely disclosure of binding US ROXUS agreement following ASX query
Response to ASX Query
75
LTR Pharma Affirms Timely Disclosure of US ROXUS Deal Amid ASX Trading Inquiry Healthcare Wrap - Week 25 (15 June -> 19 June) 2026 Wrap
11 June 2026 · 08:38 am AEST ⚡ Price SensitiveMaterial ASX Filing
LTR Secures Exclusive U.S. Pharmacy Partner for ROXUS
LTR Pharma secures exclusive US pharmacy partner for ROXUS® ahead of commercial launch
Progress Report
80
LTR Pharma Secures Exclusive US Pharmacy Partner to Boost ROXUS Launch Healthcare Wrap - Week 24 (8 June -> 12 June) 2026 Wrap
9 June 2026 · 08:35 am AEST ⚡ Price SensitiveMaterial ASX Filing
LTR Secures First U.S. Commercial Agreement for ROXUS
LTR Pharma signs binding U.S. telehealth deal with Shed Holdings for ROXUS commercialisation
Progress Report
85
LTR Pharma Locks in US Telehealth Deal with 150,000-Unit ROXUS Target Market Wrap - Week 24 (8 June -> 12 June) 2026 Wrap Healthcare Wrap - Week 24 (8 June -> 12 June) 2026 Wrap